Copyright Reports & Markets. All rights reserved.

Global Psoriasis Drug Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Psoriasis Drug Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Psoriasis Drug Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Psoriasis Drug Market Size Growth Rate by Type
    • 1.4.2 External Use
    • 1.4.3 Oral
    • 1.4.4 Injection
  • 1.5 Market by Application
    • 1.5.1 Global Psoriasis Drug Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Drugs Store
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Psoriasis Drug Market Size, Estimates and Forecasts
    • 2.1.1 Global Psoriasis Drug Revenue 2015-2026
    • 2.1.2 Global Psoriasis Drug Sales 2015-2026
  • 2.2 Global Psoriasis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Psoriasis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Psoriasis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Psoriasis Drug Competitor Landscape by Players

  • 3.1 Psoriasis Drug Sales by Manufacturers
    • 3.1.1 Psoriasis Drug Sales by Manufacturers (2015-2020)
    • 3.1.2 Psoriasis Drug Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Psoriasis Drug Revenue by Manufacturers
    • 3.2.1 Psoriasis Drug Revenue by Manufacturers (2015-2020)
    • 3.2.2 Psoriasis Drug Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Psoriasis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Psoriasis Drug Revenue in 2019
    • 3.2.5 Global Psoriasis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Psoriasis Drug Price by Manufacturers
  • 3.4 Psoriasis Drug Manufacturing Base Distribution, Product Types
    • 3.4.1 Psoriasis Drug Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Psoriasis Drug Product Type
    • 3.4.3 Date of International Manufacturers Enter into Psoriasis Drug Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Psoriasis Drug Market Size by Type (2015-2020)
    • 4.1.1 Global Psoriasis Drug Sales by Type (2015-2020)
    • 4.1.2 Global Psoriasis Drug Revenue by Type (2015-2020)
    • 4.1.3 Psoriasis Drug Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Psoriasis Drug Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Psoriasis Drug Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Psoriasis Drug Revenue Forecast by Type (2021-2026)
    • 4.2.3 Psoriasis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Psoriasis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Psoriasis Drug Market Size by Application (2015-2020)
    • 5.1.1 Global Psoriasis Drug Sales by Application (2015-2020)
    • 5.1.2 Global Psoriasis Drug Revenue by Application (2015-2020)
    • 5.1.3 Psoriasis Drug Price by Application (2015-2020)
  • 5.2 Psoriasis Drug Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Psoriasis Drug Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Psoriasis Drug Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Psoriasis Drug Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Psoriasis Drug by Country
    • 6.1.1 North America Psoriasis Drug Sales by Country
    • 6.1.2 North America Psoriasis Drug Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Psoriasis Drug Market Facts & Figures by Type
  • 6.3 North America Psoriasis Drug Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Psoriasis Drug by Country
    • 7.1.1 Europe Psoriasis Drug Sales by Country
    • 7.1.2 Europe Psoriasis Drug Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Psoriasis Drug Market Facts & Figures by Type
  • 7.3 Europe Psoriasis Drug Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Psoriasis Drug by Region
    • 8.1.1 Asia Pacific Psoriasis Drug Sales by Region
    • 8.1.2 Asia Pacific Psoriasis Drug Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Psoriasis Drug Market Facts & Figures by Type
  • 8.3 Asia Pacific Psoriasis Drug Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Psoriasis Drug by Country
    • 9.1.1 Latin America Psoriasis Drug Sales by Country
    • 9.1.2 Latin America Psoriasis Drug Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Psoriasis Drug Market Facts & Figures by Type
  • 9.3 Central & South America Psoriasis Drug Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Psoriasis Drug by Country
    • 10.1.1 Middle East and Africa Psoriasis Drug Sales by Country
    • 10.1.2 Middle East and Africa Psoriasis Drug Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Psoriasis Drug Market Facts & Figures by Type
  • 10.3 Middle East and Africa Psoriasis Drug Market Facts & Figures by Application

11 Company Profiles

  • 11.1 AbbVie
    • 11.1.1 AbbVie Corporation Information
    • 11.1.2 AbbVie Description and Business Overview
    • 11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AbbVie Psoriasis Drug Products Offered
    • 11.1.5 AbbVie Related Developments
  • 11.2 Johnson & Johnson
    • 11.2.1 Johnson & Johnson Corporation Information
    • 11.2.2 Johnson & Johnson Description and Business Overview
    • 11.2.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Johnson & Johnson Psoriasis Drug Products Offered
    • 11.2.5 Johnson & Johnson Related Developments
  • 11.3 Bayer
    • 11.3.1 Bayer Corporation Information
    • 11.3.2 Bayer Description and Business Overview
    • 11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Bayer Psoriasis Drug Products Offered
    • 11.3.5 Bayer Related Developments
  • 11.4 Galderma
    • 11.4.1 Galderma Corporation Information
    • 11.4.2 Galderma Description and Business Overview
    • 11.4.3 Galderma Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Galderma Psoriasis Drug Products Offered
    • 11.4.5 Galderma Related Developments
  • 11.5 Bristol-Myers Squibb
    • 11.5.1 Bristol-Myers Squibb Corporation Information
    • 11.5.2 Bristol-Myers Squibb Description and Business Overview
    • 11.5.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Bristol-Myers Squibb Psoriasis Drug Products Offered
    • 11.5.5 Bristol-Myers Squibb Related Developments
  • 11.6 Novartis
    • 11.6.1 Novartis Corporation Information
    • 11.6.2 Novartis Description and Business Overview
    • 11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Novartis Psoriasis Drug Products Offered
    • 11.6.5 Novartis Related Developments
  • 11.7 Pfizer
    • 11.7.1 Pfizer Corporation Information
    • 11.7.2 Pfizer Description and Business Overview
    • 11.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Pfizer Psoriasis Drug Products Offered
    • 11.7.5 Pfizer Related Developments
  • 11.8 Merz Pharma
    • 11.8.1 Merz Pharma Corporation Information
    • 11.8.2 Merz Pharma Description and Business Overview
    • 11.8.3 Merz Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Merz Pharma Psoriasis Drug Products Offered
    • 11.8.5 Merz Pharma Related Developments
  • 11.9 Valeant
    • 11.9.1 Valeant Corporation Information
    • 11.9.2 Valeant Description and Business Overview
    • 11.9.3 Valeant Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Valeant Psoriasis Drug Products Offered
    • 11.9.5 Valeant Related Developments
  • 11.10 LEO Pharma
    • 11.10.1 LEO Pharma Corporation Information
    • 11.10.2 LEO Pharma Description and Business Overview
    • 11.10.3 LEO Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 LEO Pharma Psoriasis Drug Products Offered
    • 11.10.5 LEO Pharma Related Developments
  • 11.1 AbbVie
    • 11.1.1 AbbVie Corporation Information
    • 11.1.2 AbbVie Description and Business Overview
    • 11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AbbVie Psoriasis Drug Products Offered
    • 11.1.5 AbbVie Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Psoriasis Drug Market Estimates and Projections by Region
    • 12.1.1 Global Psoriasis Drug Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Psoriasis Drug Revenue Forecast by Regions 2021-2026
  • 12.2 North America Psoriasis Drug Market Size Forecast (2021-2026)
    • 12.2.1 North America: Psoriasis Drug Sales Forecast (2021-2026)
    • 12.2.2 North America: Psoriasis Drug Revenue Forecast (2021-2026)
    • 12.2.3 North America: Psoriasis Drug Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Psoriasis Drug Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Psoriasis Drug Sales Forecast (2021-2026)
    • 12.3.2 Europe: Psoriasis Drug Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Psoriasis Drug Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Psoriasis Drug Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Psoriasis Drug Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Psoriasis Drug Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Psoriasis Drug Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Psoriasis Drug Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Psoriasis Drug Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Psoriasis Drug Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Psoriasis Drug Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Psoriasis Drug Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Psoriasis Drug Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Psoriasis Drug Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Psoriasis Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Psoriasis Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Psoriasis Drug Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Psoriasis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Psoriasis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Psoriasis Drug market is segmented into
    External Use
    Oral
    Injection

    Segment by Application, the Psoriasis Drug market is segmented into
    Hospital
    Drugs Store

    Regional and Country-level Analysis
    The Psoriasis Drug market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Psoriasis Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Psoriasis Drug Market Share Analysis
    Psoriasis Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Psoriasis Drug business, the date to enter into the Psoriasis Drug market, Psoriasis Drug product introduction, recent developments, etc.

    The major vendors covered:
    AbbVie
    Johnson & Johnson
    Bayer
    Galderma
    Bristol-Myers Squibb
    Novartis
    Pfizer
    Merz Pharma
    Valeant
    LEO Pharma
    GlaxoSmithKline

    Buy now